腰椎融合术后长期阿片类药物使用的预测因素
这项基于人群的回顾性队列研究纳入8377例21至63岁接受腰椎融合术的商业保险成人,使用多变量逻辑回归分析长期阿片类药物使用(术后24个月内阿片类药物处方覆盖≥365天)的危险因素。术前一年阿片类药物使用时长、再融合手术和抑郁症诊断与风险升高相关,前路融合与风险轻度降低相关。
要点
- 术前一年阿片类药物使用时长与术后长期使用风险呈剂量依赖关系。
- 再融合手术(OR=1.32)和抑郁症诊断(OR=1.43)与长期阿片使用风险升高相关。
- 前路融合与长期阿片使用风险轻度降低相关(OR=0.79)。
核心结论
- 这些发现可能为医生、患者及其家属提供关于腰椎融合术后阿片依赖危险因素的临床相关信息。
研究设计与样本
- 基于人群的回顾性队列研究,使用美国最大商业保险数据库之一,纳入2009年1月1日至2012年12月31日期间接受腰椎脊柱融合术的8377例21至63岁成人。
- 长期阿片类药物使用定义为腰椎融合术后24个月内阿片类药物处方覆盖≥365天。
- 采用多变量逻辑回归计算调整后的比值比(OR)和95%置信区间。
- 证据等级为3。
主要发现
- 调整协变量后,术前一年阿片类药物使用时长与长期使用风险升高相关:以0天为参照,第1四分位(1-22天)OR=2.27(95%CI=1.48-3.49),第2四分位(23-72天)OR=5.94(95%CI=4.00-8.83),第3四分位(73-250天)OR=25.31(95%CI=17.26-37.10),第4四分位(≥250天)OR=219.95(95%CI=148.53-325.71)。
- 再融合手术与长期阿片使用风险升高相关(OR=1.32,95%CI=1.02-1.72)。
- 抑郁症诊断与长期阿片使用风险升高相关(OR=1.43,95%CI=1.18-1.74)。
- 前路融合与长期阿片使用风险轻度降低相关(OR=0.79,95%CI=0.63-0.99)。
关键数值与推荐
- 长期阿片类药物使用定义为腰椎融合术后24个月内阿片类药物处方覆盖≥365天。
- 术前一年阿片使用0天为参照,第1四分位(1-22天)OR=2.27(95%CI=1.48-3.49)。
- 第2四分位(23-72天)OR=5.94(95%CI=4.00-8.83)。
- 第3四分位(73-250天)OR=25.31(95%CI=17.26-37.10)。
- 第4四分位(≥250天)OR=219.95(95%CI=148.53-325.71)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY DESIGN: A population-based retrospective cohort study. OBJECTIVE: The aim of this study was to examine risk factors for long-term opioid use following lumbar spinal fusion surgery in a nationally representative cohort of commercially insured adults. SUMMARY OF BACKGROUND DATA: Opioid prescription rates for the management of low back pain have more than doubled in the US over the past decade. Although opioids are commonly used for the management of pain following lumbar spinal fusion surgery, to date, no large-scale nationally representative studies have examined the risk factors for long-term opioid use following such surgical intervention. METHODS: Using one of the nation's largest commercial insurance databases, we conducted a retrospective cohort study of 8377 adults, aged 21 to 63 years, who underwent lumbar spinal fusion surgery between January 1, 2009, and December 31, 2012. Long-term opioid use was defined as ≥365 days of filled opioid prescriptions in the 24 months following lumbar fusion. Multivariable logistic regression was used to calculate adjusted odds ratios (ORs) and 95% confidence intervals for the risk of long-term opioid use following lumbar fusion. RESULTS: After adjusting for covariates, the following factors were associated with an increased risk of long-term opioid use following surgery: duration of opioid use in the year before lumbar surgery [Referent (0 days); Quartile 1 (1-22 days) OR = 2.27, 95% CI = 1.48-3.49; Quartile 2 (23-72 days): OR = 5.94, 95% CI = 4.00-8.83; Quartile 3: (73-250 days) OR = 25.31, 95% CI = 17.26-37.10; Quartile 4 (≥250 days) OR = 219.95, 95% CI = 148.53-325.71)], refusion surgery (OR = 1.32, 95% CI = 1.02-1.72), and diagnosis of depression (OR = 1.43, 95% CI = 1.18-1.74). Receipt of anterior fusion was associated with a modest decrease in the risk of long-term opioid use (OR = 0.79, 95% CI = 0.63-0.99). CONCLUSION: These findings may provide clinically relevant information to physicians, patients, and their families regarding the risk factors for opioid dependence following lumbar fusion surgery. LEVEL OF EVIDENCE: 3.
引用
- Connolly J, Javed Z, Raji MA, et al. Predictors of Long-term Opioid Use Following Lumbar Fusion Surgery. Spine (Phila Pa 1976). 2017. PMID: 28263225. doi:10.1097/BRS.0000000000002133
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。